Tricuspid Regurgitation Tr clinical trials

Explore recruiting tricuspid regurgitation tr clinical trials.

Recruiting tricuspid regurgitation tr studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Tricuspid Regurgitation Tr trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PERCUTANEOUS EMBOLECTOMY, LOW DOSE THROMBOLYSIS OR HEPARIN FOR INTERMEDIATE HIGH RISK PULMONARY EMBOLISM

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Tricuspid Regurgitation Tr trials by city

Tricuspid Regurgitation Tr in Toronto Tricuspid Regurgitation Tr in Vancouver Tricuspid Regurgitation Tr in Montreal Tricuspid Regurgitation Tr in Calgary Tricuspid Regurgitation Tr in Edmonton Tricuspid Regurgitation Tr in Ottawa Tricuspid Regurgitation Tr in Winnipeg Tricuspid Regurgitation Tr in Quebec City Tricuspid Regurgitation Tr in Hamilton Tricuspid Regurgitation Tr in Kitchener Tricuspid Regurgitation Tr in London Tricuspid Regurgitation Tr in Halifax Tricuspid Regurgitation Tr in New York Tricuspid Regurgitation Tr in Los Angeles Tricuspid Regurgitation Tr in Chicago Tricuspid Regurgitation Tr in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease